Skip to main content

Find Clinical Trials

Home
Conditions
Patients With Solid Tumors Receiving Immunotherapy With an ICI Will be Randomized to Participate in an SDoH and Side Effects Navigation Program vs. Control

Clinical trial condition

Patients With Solid Tumors Receiving Immunotherapy With an ICI Will be Randomized to Participate in an SDoH and Side Effects Navigation Program vs. Control

Explore clinical trials studying Patients With Solid Tumors Receiving Immunotherapy With an ICI Will be Randomized to Participate in an SDoH and Side Effects Navigation Program vs. Control. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Patients With Solid Tumors Receiving Immunotherapy With an ICI Will be Randomized to Participate in an SDoH and Side Effects Navigation Program vs. Control trial results

Completed

Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy

NCT04283539

Conditions: Cancer, Immunotherapy, Neoplasms, +4 more
Locations: National Jewish Health Denver, Colorado, United States

The Melanoma and Skin Cancer Institute Denver, Colorado, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details